{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:08:08Z","timestamp":1789571288693,"version":"build-2803163510"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Adult attention-deficit\/hyperactivity disorder (ADHD) diagnoses are rising, yet distinctions between those diagnosed in childhood or adolescence vs adulthood remain underexplored.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n To characterize differences in demographic, clinical, and genetic profiles between adults with ADHD diagnosed in childhood or adolescence (youth-diagnosed) vs adulthood (adult-diagnosed), and to compare the profile of each group with that from matched individuals without ADHD.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This cross-sectional, multicenter study used data collected in the All of Us Research Program, a nationwide US cohort integrating clinical and genetic data, from June 2017 to September 2023. Analyses were performed between July and December 2025. Participants were adults who self-reported an ADHD diagnosis, dichotomized by age at first diagnosis into youth-diagnosed (0-17 years) and adult-diagnosed (\u226518 years) ADHD groups. Each ADHD group was independently matched 1:2 via propensity scores to controls without ADHD on age, sex, race and ethnicity, educational attainment, and income.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcomes were self-reported psychiatric or somatic co-occurring conditions, measures of functional impairment (general health and daily functioning), and ADHD polygenic risk scores.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Of 13\u202f527 adults with ADHD, 3853 (28.5%; mean [SD] age, 34.8 [11.5] years; 71.5% female) were youth-diagnosed and 9674 (71.5%; mean [SD] age, 43.8 [14.3] years; 75.3% female) adult-diagnosed. Adult-diagnosed individuals were older and had higher educational attainment (eg, 548 [14.2%] vs 2690 [27.8%] for advanced degree) and annual household income (eg, 364 [9.4%] vs 1407 [14.5%] for $100\u202f001-$150\u202f000). Adjusting for age and sex, adult- versus youth-diagnosed ADHD was associated with lower adjusted probabilities of most psychiatric comorbidities (8 of 9 conditions) with the largest absolute differences for posttraumatic stress disorder (\u22127.50 [95% CI, \u22129.25 to \u22125.88] percentage points [pp]), bipolar disorder (\u22127.44 [95% CI, \u22128.99 to \u22126.00] pp), and personality disorder (\u22124.78 [95% CI, \u22125.89 to \u22123.81] pp). For somatic conditions (6 of 9 categories), the largest absolute differences were for lung conditions (\u22127.88 [95% CI, \u22129.73 to \u22125.79] pp), digestive conditions (\u22127.27 [95% CI, \u22129.12 to \u22125.28] pp), and bone, joint, and muscle conditions (\u22127.00 [95% CI, \u22128.78 to \u22125.20] pp). For impairment in overall health and daily functioning (7 of 9 measures), the largest absolute differences were for physical health (\u22123.63 [95% CI, \u22124.83 to \u22122.44] pp), being bothered by emotional problems in the past 7 days (\u22122.51 [95% CI, \u22123.79 to \u22121.24] pp), and general health (\u22122.26 [95% CI, \u22123.40 to \u22121.18] pp). Compared with their matched controls without ADHD, both ADHD groups showed markedly higher probability differences of comorbid psychiatric (eg, for depression, 39.33 [95% CI, 38.19-40.48] pp for adult-diagnosed ADHD and 36.92 [95% CI, 35.05-38.83] pp for youth-diagnosed ADHD) and somatic (eg, for brain and nervous system conditions, 21.86 [95% CI, 20.64-22.93] pp for adult-diagnosed ADHD and 22.84 [95% CI, 21.05-24.83] pp for youth-diagnosed ADHD) conditions, and functional impairments (eg, for bothered by emotional problems past 7 days, 6.11 [95% CI, 5.45-6.80] pp for adult-diagnosed ADHD and 7.29 [95% CI, 5.99-8.60] pp for youth-diagnosed ADHD). ADHD polygenic risk scores were lower in adult- vs youth-diagnosed groups (Cohen\n d<\/jats:italic>\n , \u22120.17 [95% CI, \u22120.21 to \u22120.12]) and higher in youth-diagnosed (Cohen\n d<\/jats:italic>\n , 0.21 [95% CI, 0.16-0.26]) and adult-diagnosed (Cohen\n d<\/jats:italic>\n , 0.12 [95% CI, 0.09-0.15]) groups compared with controls.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cross-sectional study of adults with ADHD, individuals first diagnosed with ADHD in adulthood showed a milder ADHD-like clinical and genetic profile than those diagnosed in childhood or adolescence, which may contribute to later recognition of the disorder. Nonetheless, adults diagnosed either as youths or adults exhibited profiles characteristic of ADHD relative to matched controls without ADHD, including substantial burden, supporting adult-diagnosed ADHD as a clinically important subgroup warranting recognition and management.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.34125","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:01:36Z","timestamp":1789570896000},"page":"e2634125","source":"Crossref","is-referenced-by-count":0,"title":["Age at Diagnosis and Clinical and Genetic Profiles Among Adults With Attention-Deficit\/Hyperactivity Disorder"],"prefix":"10.1001","volume":"9","author":[{"given":"Douglas Teixeira","family":"Leffa","sequence":"first","affiliation":[{"name":"Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme","family":"Bauer-Negrini","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Bellaver","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firoza Z.","family":"Lussier","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela C. L.","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme","family":"Povala","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Cortese","sequence":"additional","affiliation":[{"name":"Developmental EPI (Evidence synthesis, Prediction, Implementation) Lab, Centre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, United Kingdom"},{"name":"Clinical and Experimental Sciences (CNS and Psychiatry), Faculty of Medicine, University of Southampton, Southampton, United Kingdom"},{"name":"Hampshire and Isle of Wight Healthcare NHS Foundation Trust, Southampton, United Kingdom"},{"name":"Hassenfeld Children\u2019s Hospital at NYU Langone, New York University Child Study Center, New York City"},{"name":"DiMePRe-J-Department of Precision and Rigenerative Medicine-Jonic Area, University of Bari \u201cAldo Moro,\u201d Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Augusto","family":"Rohde","sequence":"additional","affiliation":[{"name":"ADHD Outpatient Program & Development Psychiatry Program, Hospital de Cl\u00ednicas de Porto Alegre, Porto Alegre, Brazil"},{"name":"National Institute of Developmental Psychiatry & National Center for Innovation and Research in Mental Health, S\u00e3o Paulo, Brazil"},{"name":"Medical Council UNIFAJ & UNIMAX, Indaiatuba, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke S. G.","family":"Molina","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania"},{"name":"Department of Psychology, University of Pittsburgh, Pittsburgh, Pennsylvania"},{"name":"Department of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania"},{"name":"Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tharick A.","family":"Pascoal","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania"},{"name":"Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"issue":"11","key":"zoi260927r1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.14344","article-title":"Trends in the prevalence and incidence of attention-deficit\/hyperactivity disorder among adults and children of different racial and ethnic groups.","volume":"2","author":"Chung","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"40","key":"zoi260927r2","doi-asserted-by":"publisher","first-page":"890","DOI":"10.15585\/mmwr.mm7340a1","article-title":"Attention-deficit\/hyperactivity disorder diagnosis, treatment, and telehealth use in adults - National Center for Health Statistics Rapid Surveys System, United States, October-November 2023.","volume":"73","author":"Staley","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"13","key":"zoi260927r3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.15585\/mmwr.mm7213a1","article-title":"Trends in stimulant prescription fills among commercially insured children and adults - United States, 2016-2021.","volume":"72","author":"Danielson","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"zoi260927r4","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1017\/S0033291723002544","article-title":"Elemental psychopathology: distilling constituent symptoms and patterns of repetition in the diagnostic criteria of the DSM-5.","volume":"54","author":"Forbes","year":"2024","journal-title":"Psychol Med"},{"issue":"8","key":"zoi260927r5","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/brainsci12081004","article-title":"Malingering and stimulant medications abuse, misuse and diversion.","volume":"12","author":"Sadek","year":"2022","journal-title":"Brain Sci"},{"issue":"6","key":"zoi260927r6","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1001\/jamapsychiatry.2025.0054","article-title":"Prescription stimulant use, misuse, and use disorder among US adults aged 18 to 64 years.","volume":"82","author":"Han","year":"2025","journal-title":"JAMA Psychiatry"},{"issue":"8091","key":"zoi260927r7","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/d41586-025-03855-2","article-title":"ADHD diagnoses are growing: what\u2019s going on?","volume":"647","author":"Pearson","year":"2025","journal-title":"Nature"},{"issue":"3","key":"zoi260927r8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.5765\/jkacap.2017.28.3.183","article-title":"Comparison of adults with attention-deficit hyperactivity disorder depending on the age of being diagnosed in childhood and adulthood: based on retrospective review in one university hospital.","volume":"28","author":"Cho","year":"2017","journal-title":"J Korean Acad Child Adolesc Psychiatry"},{"issue":"5","key":"zoi260927r9","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1177\/10870547231218450","article-title":"ADHD in adults: does age at diagnosis matter?","volume":"28","author":"Hutt Vater","year":"2024","journal-title":"J Atten Disord"},{"issue":"7","key":"zoi260927r10","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1056\/NEJMsr1809937","article-title":"The \u201cAll of Us\u201d Research Program.","volume":"381","author":"Denny","year":"2019","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi260927r11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies.","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"8003","key":"zoi260927r12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41586-023-06957-x","article-title":"Genomic data in the All of Us Research Program.","volume":"627","author":"Bick","year":"2024","journal-title":"Nature"},{"issue":"9","key":"zoi260927r13","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1093\/bioinformatics\/btu848","article-title":"PRSice: Polygenic Risk Score software.","volume":"31","author":"Euesden","year":"2015","journal-title":"Bioinformatics"},{"issue":"2","key":"zoi260927r14","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41588-022-01285-8","article-title":"Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains.","volume":"55","author":"Demontis","year":"2023","journal-title":"Nat Genet"},{"issue":"2","key":"zoi260927r15","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.1608","article-title":"A tutorial on conducting genome-wide association studies: quality control and statistical analysis.","volume":"27","author":"Marees","year":"2018","journal-title":"Int J Methods Psychiatr Res"},{"issue":"7","key":"zoi260927r16","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/gepi.22339","article-title":"A principal component approach to improve association testing with polygenic risk scores.","volume":"44","author":"Coombes","year":"2020","journal-title":"Genet Epidemiol"},{"issue":"1","key":"zoi260927r17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-024-00495-0","article-title":"Attention-deficit\/hyperactivity disorder.","volume":"10","author":"Faraone","year":"2024","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"zoi260927r18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11920-016-0750-x","article-title":"Life span studies of ADHD-conceptual challenges and predictors of persistence and outcome.","volume":"18","author":"Caye","year":"2016","journal-title":"Curr Psychiatry Rep"},{"issue":"3","key":"zoi260927r19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/wps.21374","article-title":"Attention-deficit\/hyperactivity disorder (ADHD) in adults: evidence base, uncertainties and controversies.","volume":"24","author":"Cortese","year":"2025","journal-title":"World Psychiatry"},{"key":"zoi260927r20","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.neubiorev.2021.10.035","article-title":"Non-mental diseases associated with ADHD across the lifespan: Fidgety Philipp and Pippi Longstocking at risk of multimorbidity?","volume":"132","author":"Kittel-Schneider","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"issue":"9","key":"zoi260927r21","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S2215-0366(21)00171-1","article-title":"Mapping phenotypic and aetiological associations between ADHD and physical conditions in adulthood in Sweden: a genetically informed register study.","volume":"8","author":"Du Rietz","year":"2021","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"zoi260927r22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/1087054716669589","article-title":"Adult ADHD and comorbid somatic disease: a systematic literature review.","volume":"22","author":"Instanes","year":"2018","journal-title":"J Atten Disord"},{"key":"zoi260927r23","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.sleep.2017.09.027","article-title":"Attention deficit hyperactivity disorder symptom severity and sleep problems in adult participants of the Netherlands sleep registry.","volume":"40","author":"Vogel","year":"2017","journal-title":"Sleep Med"},{"issue":"4","key":"zoi260927r24","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jaac.2014.01.009","article-title":"Childhood attention-deficit\/hyperactivity disorder symptoms are risk factors for obesity and physical inactivity in adolescence.","volume":"53","author":"Khalife","year":"2014","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"zoi260927r25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1037\/0003-066X.49.1.15","article-title":"Socioeconomic status and health: the challenge of the gradient.","volume":"49","author":"Adler","year":"1994","journal-title":"Am Psychol"},{"key":"zoi260927r26","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.neubiorev.2021.01.022","article-title":"The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder.","volume":"128","author":"Faraone","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"zoi260927r27","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1017\/S003329171100153X","article-title":"The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).","volume":"42","author":"Bernardi","year":"2012","journal-title":"Psychol Med"},{"issue":"2","key":"zoi260927r28","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41588-023-01593-7","article-title":"Polygenic profiles define aspects of clinical heterogeneity in attention deficit hyperactivity disorder.","volume":"56","author":"LaBianca","year":"2024","journal-title":"Nat Genet"},{"issue":"8","key":"zoi260927r29","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/s41588-022-01143-7","article-title":"Differences in the genetic architecture of common and rare variants in childhood, persistent and late-diagnosed attention-deficit hyperactivity disorder.","volume":"54","author":"Rajagopal","year":"2022","journal-title":"Nat Genet"},{"issue":"7","key":"zoi260927r30","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1007\/s00787-024-02622-4","article-title":"Enhanced neurobiological biomarker differentiation for attention-deficit\/hyperactivity disorder through a risk-informed design.","volume":"34","author":"Duarte","year":"2025","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"zoi260927r31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jpsychires.2022.07.032","article-title":"Examining the impact of ADHD polygenic risk scores on ADHD and associated outcomes: A systematic review and meta-analysis.","volume":"155","author":"Green","year":"2022","journal-title":"J Psychiatr Res"},{"issue":"10","key":"zoi260927r32","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.jaac.2021.01.019","article-title":"Systematic review: how the attention-deficit\/hyperactivity disorder polygenic risk score adds to our understanding of ADHD and associated traits.","volume":"60","author":"Ronald","year":"2021","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"zoi260927r33","doi-asserted-by":"publisher","first-page":"e421","DOI":"10.4088\/JCP.14m09630","article-title":"Gender differences in adult attention-deficit\/hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).","volume":"77","author":"Cortese","year":"2016","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"zoi260927r34","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1017\/S2045796015000876","article-title":"Gender-related patterns and determinants of recent help-seeking for past-year affective, anxiety and substance use disorders: findings from a national epidemiological survey.","volume":"25","author":"Harris","year":"2016","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"7","key":"zoi260927r35","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1001\/jamapsychiatry.2016.0465","article-title":"Evaluation of the persistence, remission, and emergence of attention-deficit\/hyperactivity disorder in young adulthood.","volume":"73","author":"Agnew-Blais","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"zoi260927r36","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/jcpp.13020","article-title":"Annual research review: does late-onset attention-deficit\/hyperactivity disorder exist?","volume":"60","author":"Asherson","year":"2019","journal-title":"J Child Psychol Psychiatry"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2854122\/leffa_2026_oi_260927_1788960869.95197.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:01:36Z","timestamp":1789570896000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2854122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.34125","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]}}}